We are live on ! Find out more
Profund Advisors

Profund Advisors Portfolio holdings

AUM $3.48B Turnover 14.37%
1-Year Est. Return 66.96%
 

ProFund Advisors manages the ProFunds mutual funds, which include index funds across sectors, bonds, currencies and crypto, as well as leveraged and inverse funds. The ProFunds brand dates from 1997, and its affiliate ProShares began offering leveraged and inverse ETFs in 2006. The Bitcoin ProFund tracks bitcoin futures rather than holding bitcoin itself.

This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+66.96%
3 Year Est. Return
+258.11%
5 Year Est. Return
+342.15%
10 Year Est. Return
+1,333.1%
AUM
$3.48B
AUM Growth
-$153M
Cap. Flow
-$155M
Cap. Flow %
-4.44%
Top 10 Hldgs %
41.36%
Holding
1,225
New
50
Increased
319
Reduced
729
Closed
126
Avg Time Held
6.2 years
Top 10 Avg Time Held
4.5 years
Top 20 Avg Time Held
5.7 years

Top Buys

Rank Stock Value
1
SPCX icon
SpaceX
SPCX
+$37.8M
2
ALMS icon
Alumis Inc
ALMS
+$2.98M
3
COLL icon
Collegium Pharmaceutical
COLL
+$1.65M
4
RDDT icon
Reddit
RDDT
+$1.57M
5
SEPN icon
Septerna Inc
SEPN
+$1.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.8M
2
AVGO icon
Broadcom
AVGO
+$15.2M
3
MU icon
Micron Technology
MU
+$13.3M
4
AAPL icon
Apple
AAPL
+$12.8M
5
AMD icon
Advanced Micro Devices
AMD
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 54.2%
2 Healthcare 10.88%
3 Communication Services 8.15%
4 Consumer Discretionary 7.38%
5 Industrials 4.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CELC icon
276
Celcuity
CELC
$3.14B
$1.45M 0.04%
18,292
+2,280
+14% +$207K
2025 Q4
3 quarters
BEKE icon
277
KE Holdings
BEKE
$19.3B
$1.45M 0.04%
86,285
-4
-0% -$67
2020 Q4
23 quarters
AMLX icon
278
Amylyx Pharmaceuticals
AMLX
$3.84B
$1.44M 0.04%
49,435
+28,725
+139% +$761K
2025 Q3
4 quarters
COLL icon
279
Collegium Pharmaceutical
COLL
$775M
$1.43M 0.04%
65,710
+56,597
+621% +$1.65M
2025 Q3
4 quarters
BLK icon
280
Blackrock
BLK
$188B
$1.42M 0.04%
1,342
+133
+11% +$145K
2013 Q2
53 quarters
ACN icon
281
Accenture
ACN
$148B
$1.4M 0.04%
7,654
-958
-11% -$162K
2013 Q2
53 quarters
DE icon
282
Deere & Co
DE
$183B
$1.4M 0.04%
2,088
-345
-14% -$219K
2013 Q2
53 quarters
MTSI icon
283
MACOM Technology Solutions
MTSI
$18.8B
$1.4M 0.04%
4,919
-203
-4% -$56.9K
2025 Q3
4 quarters
SRRK icon
284
Scholar Rock
SRRK
$5.27B
$1.4M 0.04%
28,908
-3,851
-12% -$203K
2023 Q4
11 quarters
ETR icon
285
Entergy
ETR
$53.5B
$1.39M 0.04%
13,992
-343
-2% -$37K
2013 Q2
53 quarters
ETN icon
286
Eaton
ETN
$139B
$1.39M 0.04%
3,229
-534
-14% -$223K
2013 Q2
53 quarters
PCRX icon
287
Pacira BioSciences
PCRX
$1.46B
$1.39M 0.04%
55,354
+42,319
+325% +$1.07M
2020 Q2
25 quarters
ETON icon
288
Eton Pharmaceutcials
ETON
$1.77B
$1.37M 0.04%
26,627
+20,093
+308% +$1.02M
2026 Q2
1 quarter
MMM icon
289
3M
MMM
$96B
$1.36M 0.04%
8,268
-691
-8% -$118K
2013 Q2
53 quarters
APD icon
290
Air Products & Chemicals
APD
$70.4B
$1.36M 0.04%
4,875
-2,435
-33% -$724K
2013 Q2
53 quarters
RDDT icon
291
Reddit
RDDT
$19.2B
$1.35M 0.04%
+9,497
New +$1.57M
2026 Q3
0 quarters
TRVI icon
292
Trevi Therapeutics
TRVI
$1.94B
$1.35M 0.04%
94,425
+73,319
+347% +$1.26M
2025 Q2
5 quarters
RLAY icon
293
Relay Therapeutics
RLAY
$3.99B
$1.35M 0.04%
74,818
-13,553
-15% -$260K
2023 Q1
14 quarters
NUVB icon
294
Nuvation Bio
NUVB
$1.43B
$1.35M 0.04%
240,483
+179,994
+298% +$1.13M
2024 Q2
9 quarters
AXSM icon
295
Axsome Therapeutics
AXSM
$7.59B
$1.34M 0.04%
7,291
+6,262
+609% +$1.36M
2022 Q4
15 quarters
UNP icon
296
Union Pacific
UNP
$181B
$1.34M 0.04%
4,940
-812
-14% -$236K
2013 Q2
53 quarters
HAL icon
297
Halliburton
HAL
$27.1B
$1.34M 0.04%
42,198
-11,107
-21% -$379K
2013 Q2
53 quarters
VST icon
298
Vistra
VST
$45.7B
$1.34M 0.04%
9,694
-433
-4% -$63.7K
2023 Q3
12 quarters
CDNA icon
299
CareDx
CDNA
$4.19B
$1.33M 0.04%
20,441
+3,923
+24% +$178K
2023 Q1
14 quarters
LOW icon
300
Lowe's Companies
LOW
$128B
$1.33M 0.04%
7,200
+119
+2% +$24.7K
2013 Q2
53 quarters
10 11
12
13 14

Similar funds

Tremblant Capital Group
Tremblant Capital Group West Palm Beach, Florida $3.48B AUM 29.32% 1-Year Est. Return
Stock Yards Bank & Trust
Stock Yards Bank & Trust Louisville, Kentucky $3.49B AUM 27.82% 1-Year Est. Return
Iconiq Capital
Iconiq Capital San Francisco, California $3.47B AUM 23.74% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $3.47B AUM 37.88% 1-Year Est. Return
Cooperman Leon G
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $3.4B AUM 30.65% 1-Year Est. Return
Voyager Global Management
Voyager Global Management New York $3.63B AUM 5.73% 1-Year Est. Return
Needham Investment Management
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

Profund Advisors's Q3 2026 Portfolio in Review

As of Q3 2026, Profund Advisors held 1,225 positions worth $3.48B, down 4.2% from $3.64B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors withdrew a net $155M in Q3 2026, closing 126 positions and reducing 729 holdings. Its most notable exit was Electronic Arts, an estimated $5.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 54% of assets, down from 56% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Profund Advisors opened a new position in SpaceX worth $41.3M.

  • Profund Advisors's largest Q3 2026 buy was SpaceX: 273,453 shares worth $41.3M.
  • Profund Advisors added most to Alumis Inc in Q3 2026, an estimated $2.98M increase.
  • Profund Advisors's biggest Q3 2026 reduction was NVIDIA, cutting an estimated $46.8M.
  • Profund Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $5.2M.
  • Profund Advisors's ten largest holdings make up 41% of its $3.48B portfolio in Q3 2026.
  • Profund Advisors opened 50 new positions and closed 126 in Q3 2026.
  • Profund Advisors's portfolio value fell 4.2% quarter-over-quarter to $3.48B.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.